Nu Skin Enterprises (NYSE:NUS) Announces Earnings Results

Nu Skin Enterprises (NYSE:NUS) issued its quarterly earnings results on Thursday. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14, Zacks reports. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. Nu Skin Enterprises updated its Q1 2025 guidance to 0.100-0.200 EPS and its FY 2025 guidance to 0.900-1.300 EPS.

Nu Skin Enterprises Stock Up 1.3 %

Shares of NUS stock traded up $0.09 on Thursday, reaching $6.41. 1,304,442 shares of the company were exchanged, compared to its average volume of 690,499. The company has a market cap of $318.40 million, a price-to-earnings ratio of -3.09 and a beta of 1.17. The company has a 50-day moving average of $6.91 and a 200-day moving average of $7.50. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. Nu Skin Enterprises has a one year low of $5.95 and a one year high of $17.68.

Analyst Ratings Changes

NUS has been the topic of a number of research analyst reports. DA Davidson cut their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. Finally, Citigroup cut their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.